Skip to content

Clinical trials

Completed Phase 2/3 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Completed Country / region: South Korea Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20062
20074
20087
20094
201012
201112
20126
20139
20147
20156
20167
20173
201811
20192
20203
20215
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed107

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chonbuk National University Hospital15
Seoul National University Hospital9
AstraZeneca3
Bayer3
Boehringer Ingelheim3
Green Cross Corporation3
Novartis Pharmaceuticals3
Samsung Medical Center3
Yonsei University3
ASLAN Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 24
COVID-193
Carcinoma, Non-Small-Cell Lung3
Colitis, Ulcerative3
Hemophilia A3
Hyperlipidemias3
Neoplasms3
Obesity3
Stomach Neoplasms3
Alopecia Areata2

Trials

Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.